Cargando…
Rational use of inhaled corticosteroids for the treatment of COPD
Inhaled corticosteroids (ICS) are the mainstay of treatment for asthma, but their role in chronic obstructive pulmonary disease (COPD) is debated. Recent randomised controlled trials (RCTs) conducted in patients with COPD and frequent or severe exacerbations demonstrated a significant reduction (~25...
Autores principales: | Quint, Jennifer K., Ariel, Amnon, Barnes, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366209/ https://www.ncbi.nlm.nih.gov/pubmed/37488104 http://dx.doi.org/10.1038/s41533-023-00347-6 |
Ejemplares similares
-
Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study
por: Bloom, Chloe I, et al.
Publicado: (2020) -
Inhaled Corticosteroids
por: Barnes, Peter J.
Publicado: (2010) -
Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021) -
Inhaled corticosteroids in COPD: Personalising the therapeutic choice
por: Shaw, J A, et al.
Publicado: (2018) -
Inhaled corticosteroids for the treatment of COVID-19
por: Bafadhel, Mona, et al.
Publicado: (2022)